I acknowledge the delays in enrollment because of COVID and how a “clear signal” would be hard to identify from only 15 patients, but that doesn’t account for NP’s silence regarding ongoing CTC and imaging results. He was very vocal about how great the results were and has been very quiet over the past couple of months, which is not typical. Yes, COVID19 is the big focus, but cancer is the potential blockbuster and NP knows this based on the BTD shares he tried to award himself.

I’m hoping we get some clarification with the Dr. Been interview. NP has been heavily focused on the COVID19 indication and for good reason, but they need to start focusing on other indications are promising and have ongoing trials.